offline
Healthcare | Drug Manufacturers - Major | USA
Biogen's stock plummets after phase 3 trial of Alzheimer's treatment discontinued
Shares of Biogen Inc. BIIB, plummeted 27% toward a near 3-year low in premarket trade Thursday, after the biotechnology company and Japan's Eisai Co. Ltd. said Thursday they have decided to discontinue late-stage trials of a treatment for Alzheimer's disease, after an independent data monitoring committee said they were unlikely to meet its primary goal.
...
https://www.marketwatch.com/story/biogen...3?mod=bnbh
Aktuell minus 28% auf 231....
![[Bild: BIIBc1dl0809.png]](https://finviz.com/publish/032119/BIIBc1dl0809.png)
Biogen's stock plummets after phase 3 trial of Alzheimer's treatment discontinued
Shares of Biogen Inc. BIIB, plummeted 27% toward a near 3-year low in premarket trade Thursday, after the biotechnology company and Japan's Eisai Co. Ltd. said Thursday they have decided to discontinue late-stage trials of a treatment for Alzheimer's disease, after an independent data monitoring committee said they were unlikely to meet its primary goal.
...
https://www.marketwatch.com/story/biogen...3?mod=bnbh
Aktuell minus 28% auf 231....
